Patents by Inventor Tsung-Jung HO

Tsung-Jung HO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963969
    Abstract: Provided is a pharmaceutical composition including gastrodin and a use thereof for the prevention or the treatment of amyotrophic lateral sclerosis. The pharmaceutical composition is effective in reducing neuronal axon degeneration and neurofibromin accumulation, improving symptoms of amyotrophic lateral sclerosis and extending life of patients of amyotrophic lateral sclerosis.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: April 23, 2024
    Assignee: BUDDHIST TZU CHI MEDICAL FOUNDATION
    Inventors: Chia-Yu Chang, Shinn-Zong Lin, Hsiao-Chien Ting, Hui-I Yang, Horng-Jyh Harn, Hong-Lin Su, Ching-Ann Liu, Yu-Shuan Chen, Tzyy-Wen Chiou, Tsung-Jung Ho
  • Publication number: 20240016873
    Abstract: Provided is an herbal composition including an extract from an herbal raw material including at least one of Artemisia argyi, Ohwia caudata, Anisomeles indica (L.) O. Ktze, Ophiopogon japonicus, Houttuynia cordata, Platycodon grandiflorus, Glycyrrhiza uralensis, Perilla frutescens, and chrysanthemum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.
    Type: Application
    Filed: December 10, 2021
    Publication date: January 18, 2024
    Inventors: Cheng-Yen SHIH, Pi-Yu LIN, Shinn-Zong LIN, Chih-Yang HUANG, Tsung-Jung HO, Chien-Yi CHIANG, Yu-Jung LIN, Marthandam Asokan SHIBU, Wai-Ling LIM
  • Publication number: 20230263813
    Abstract: Provided is a pharmaceutical composition including gastrodin and a use thereof for the prevention or the treatment of amyotrophic lateral sclerosis. The pharmaceutical composition is effective in reducing neuronal axon degeneration and neurofibromin accumulation, improving symptoms of amyotrophic lateral sclerosis and extending life of patients of amyotrophic lateral sclerosis.
    Type: Application
    Filed: September 16, 2022
    Publication date: August 24, 2023
    Inventors: Chia-Yu CHANG, Shinn-Zong LIN, Hsiao-Chien TING, Hui-I YANG, Horng-Jyh HARN, Hong-Lin SU, Ching-Ann LIU, Yu-Shuan CHEN, Tzyy-Wen CHIOU, Tsung-Jung HO